• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,085
2,275
1,819
1,803
1,709

COUNTRY

827
638
256
247
206

CATEGORIES

  • 856
  • 184
  • 950
  • 1,127
    • 99
  • 385
  • 270
  • 252
  • 65
  • 379
  • 673
  • 1,257
  • 1,621
  • 625
  • 883
  • 1,673
  • 2,638
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 727
  • 0
  • 97

PRICE

6,631
11,254
16,937
24,673

PUBLISHED

1,611
3,141
7,005
24,673

PRODUCT TYPE

20,300
3,174
856
164
74
44
21
21
12
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Influenza A Infections - Pipeline Review, H2 2013

Influenza A Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza A Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Kidney Disease - Pipeline Review, H2 2013

Kidney Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Kidney Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Scar - Pipeline Review, H2 2013

Scar - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Scar - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Encephalitis - Pipeline Review, H2 2013

Encephalitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Encephalitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Pyelonephritis - Pipeline Review, H2 2013

Pyelonephritis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Pyelonephritis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Huntington's Disease - Pipeline Review, H2 2013

Huntington's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Huntington's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Atrial Fibrillation - Pipeline Review, H2 2013

Atrial Fibrillation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Atrial Fibrillation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013', provides an overview...

August 2013
FROM

Osteoporosis - Pipeline Review, H2 2013

Osteoporosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Osteoporosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Non-Hodgkin Lymphoma - Pipeline Review, H2 2013

Non-Hodgkin Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Non-Hodgkin Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Atherosclerosis - Pipeline Review, H2 2013

Atherosclerosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Atherosclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

August 2013
FROM

Osteoarthritis Pain - Pipeline Review, H2 2013

Osteoarthritis Pain - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Osteoarthritis Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Contraception - Pipeline Review, H2 2013

Contraception - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Contraception - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Urinary Tract Infections - Pipeline Review, H2 2013

Urinary Tract Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Urinary Tract Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Multiple Sclerosis - Pipeline Review, H2 2013

Multiple Sclerosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Psoriasis - Pipeline Review, H2 2013

Psoriasis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Psoriasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Crohn's Disease - Pipeline Review, H2 2013

Crohn's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Crohn's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Eosinophilic Esophagitis - Pipeline Review, H2 2013

Eosinophilic Esophagitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Eosinophilic Esophagitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Periodontal Disease - Pipeline Review, H2 2013

Periodontal Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Periodontal Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM
Loading Indicator

Our Clients

Our clients' logos